6936 Yung Hung Biotech: Announces Board Approval of 115 Q2 Individual Financial Report

Release Date: July 28, 115 Statement Date: July 27, 115 Statement Time: 19:51:12 Company Code: 6936 Company Name: Yung Hung Biotech Subject: Announcement of the Board of Directors' Approval of the Individual Financial Report for the Second Quarter of Year 115 Applicable Clause: Clause 31 Factual Date: July 27, 115

Details: 1. Date reported to or resolved by the board of directors: July 27, 115 2. Date approved by the Audit Committee: July 23, 115 3. Reporting period for financial report or year-end self-prepared financial information (start ~ end): January 1, 115 ~ June 30, 115 4. Cumulative operating revenue from January 1 to the end of the current period (in NT$ thousands): 744,081 5. Cumulative operating gross profit (loss) from January 1 to the end of the current period (in NT$ thousands): 278,151 6. Cumulative operating income (loss) from January 1 to the end of the current period (in NT$ thousands): 103,961 7. Cumulative pre-tax net profit (loss) from January 1 to the end of the current period (in NT$ thousands): 104,381 8. Cumulative net profit (loss) for the current period from January 1 (in NT$ thousands): 83,142 9. Cumulative net profit (loss) attributable to owners of the parent company from January 1 to the end of the current period (in NT$ thousands): 83,142 10. Cumulative basic earnings (loss) per share from January 1 to the end of the current period (in NT$): 1.14 11. Total assets at the end of the period (in NT$ thousands): 1,775,117 12. Total liabilities at the end of the period (in NT$ thousands): 449,670 13. Equity attributable to owners of the parent company at the end of the period (in NT$ thousands): 1,325,447 14. Other matters to be disclosed: None